Loading
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Latest filing published 20 Aug 2024 for ARCA biopharma, Inc., €14k. Read the official filing
Filing timeline
BuySaleJanus Henderson Group PLC
Insider track record
Disclosed buys
4
Disclosed sells
0
Signal history
Closed purchases
Market purchases
4
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Janus Henderson Group PLC: trading record in brief
Janus Henderson Group PLC is a declared insider of Oruka Therapeutics, Inc., with filings sourced from SEC (Form 4). In total, 4 filings cover trades dated from 3 July 2024 to 16 August 2024.
Purchases make up the whole of the open-market record (4 purchases, €1.0M). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
Half of the purchases are above €251k and half below. The 4 purchases reviewed show no overlap with other insiders buying the same stock within a month.
The record was last updated on 20 August 2024 with an open-market purchase (€14k) in Oruka Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Janus Henderson Group PLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
5,390 shares@ US$2.931.4% of flowCommon StockSEC:0001437749-24-027344:0
Canonical exit: 14 Nov 2024 (T+90)
428 shares@ US$2.97680.1% of flowCommon StockSEC:0001437749-24-027344:1
Canonical exit: 14 Nov 2024 (T+90)
165,000 shares@ US$3.2046.4% of flowCommon StockSEC:0001437749-24-023533:0
Canonical exit: 22 Oct 2024 (T+90)
166,042 shares@ US$3.550752.1% of flowCommon StockSEC:0001437749-24-022708:0
Canonical exit: 1 Oct 2024 (T+90)
4 of 4 declarations
